Johnson Wu


Johnson is a Consultant at PRMA Consulting who provides market access insights through landscape analyses, critical HTA reviews, and gap analyses with evidence generation strategies for MM, NSCLC, and other oncology assets.

He has conducted primary research over the positioning of an innovative gMG treatment and pricing analysis for an innovative MM treatment.

He is a licensed pharmacist in Taiwan and holds an MSc in Health Economics and Decision Modeling from the University of Sheffield, with previous experience in UCB UK’s market access team and Sanofi Taiwan’s medical team.

Outside of work, Johnson enjoys cycling, traveling, and learning about different fields.